← Russell 3000 cross-section

KIDS ORTHOPEDIATRICS CORP

Trailing twelve months to 2026-06-30 · as filed 2026-08-05, not restated
Healthcare

Scale

Market cap
$621m
Revenue TTM
$253m
Net income TTM
$-40m
Free cash flow
$-2m
Composite score
42.1
Sector rank
#2293

Valuation

P / E
EV / EBITDA
EV / sales
2.7
FCF yield
-0.30%
Earnings yield vs 10-yr
-11.13pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
-15.7%
EBITDA margin
-3.0%
ROE
-11.6%
ROIC
-7.5%
Revenue growth
14.5%

Insider activity, last 90 days

Net open-market
$-2.83m
Buyers
0
Sellers
3

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

Accordingly, we must make an up-front investment in inventory of consigned implants and instruments before we can generate revenue from a particular hospital and we maintain substantial levels of inventory at any given time. These arrangements have generated an increase in revenue and gross margin. For the six months ended June 30, 2026, consignment sales accounted for approximately 60% of our total net sales. Inventory held on consignment at sales agencies, distributors, or other customers is approximately 60% of gross inventory. Net revenue increased $16.4 million, or 14%, from $113.5 million for the six months ended June 30, 2025 to $129.9 million for the six months ended June 30, 2026. …ORTHOPEDIATRICS CORP, 10-Q, period ended 2026-06-30, filed 2026-08-05

Read the full passage →